1. Breast cancer genomics and immuno-oncological markers to guide immune therapies
    D. Hammerl et al, 2018, Seminars in Cancer Biology CrossRef
  2. The effect of apis Dorsata honey as a complementary therapy to interleukin-6 (IL-6) levels and T lymphocytes of post-chemotherapy breast cancer patients
    Yuliana Syam et al, 2021, Breast Disease CrossRef
  3. Cytotoxic T-lymphocyte associated-protein-4 +49A/G-allele (rs231775) single nucleotide polymorphisms are associated with acute allograft renal transplantation rejection: A multilevel modelling of meta-analysis
    Besut Daryanto et al, 2022, F1000Research CrossRef
  4. Synergistic antitumor effect of anti‐PD‐L1 combined with oxaliplatin on a mouse tumor model
    Soheila Golchin et al, 2019, Journal of Cellular Physiology CrossRef
  5. Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
    Qi Chen et al, 2019, Diagnostic Pathology CrossRef
  6. Progress in research and treatment of immune checkpoints in breast cancer
    Xinyi Zhang et al, 2024, Asia-Pacific Journal of Oncology CrossRef
  7. Association of cytotoxic T‐lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation
    Chun‐Hua Yang et al, 2017, Pediatric Transplantation CrossRef
  8. References
    , 2017, Molecular Approach to Cancer Management CrossRef
  9. Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions
    Kamil Grubczak et al, 2021, Cells CrossRef
  10. PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer
    Xiaojun Shi et al, 2017, Cancer Letters CrossRef
  11. Combination immunotherapy with interleukin‐2 surface‐modified tumor cell vaccine and programmed death receptor‐1 blockade against renal cell carcinoma
    Xinji Zhang et al, 2019, Cancer Science CrossRef
  12. PD‐1 blockade enhances the antitumor efficacy of GM‐CSF surface‐modified bladder cancer stem cells vaccine
    Xiaojun Shi et al, 2018, International Journal of Cancer CrossRef